N-Acetyl Cysteine 600mg | NAC Glutathione Precursor for Antioxidant & Longevity Support

The 30-second answer

N-Acetyl Cysteine (NAC) is the rate-limiting precursor to glutathione — the master endogenous antioxidant your body manufactures inside every cell to scavenge oxidative damage, recycle vitamins C and E, support immune function, and defend against the chronic free-radical pressure that drives aging. The body builds glutathione (GSH) from three amino acids (cysteine, glycine, glutamate); of those three, cysteine is the bottleneck. NAC is cysteine in a stable, bioavailable, sulfur-thiol-protected form. Take it and your cells make more glutathione — especially as you get older, when intracellular glutathione drops 30–60% and oxidative stress rises in lockstep. NAC has a 50-year clinical track record (paracetamol-overdose antidote on the WHO Essential Medicines list, cystic-fibrosis mucolytic, contrast-induced nephropathy prevention, OCD adjunct) and is now the headline ingredient in the GlyNAC aging-reversal trials at Baylor College of Medicine — half of the only nutrient combination ever shown in published human work to roll back ~22 measured hallmarks of aging in older adults (Kumar 2021, Clin Transl Med; Kumar 2022, J Gerontol A Biol Sci Med Sci).

If you are already running NMN, NAD+, or sirtuin activators, NAC is the antioxidant arm of the stack: it protects the lipid bilayers, mitochondrial cristae, and DNA from the oxidative byproducts of the very mitochondrial activity those NAD+ precursors are accelerating. Boost mitochondrial output without restoring antioxidant defenses and you are running an engine harder without changing the oil. NAC is the oil change.

Why a hospital antidote ended up on every longevity stack

NAC isn't new. It has been used in clinical medicine since the 1960s — first as Mucomyst, an inhaled mucolytic for cystic fibrosis (its free thiol breaks the disulfide bridges that crosslink mucus glycoproteins into a thick, immobile gel), and since the 1970s as the standard ER antidote for acetaminophen overdose: pre-empt the liver's glutathione collapse by giving it more cysteine, save the patient. That's how doctors know NAC works as a glutathione precursor — the receipts are 50 years of liver transplants not happening. The Rumack-Matthew nomogram and the FDA-approved 21-hour IV NAC protocol (Smilkstein 1988, NEJM) have made it one of the most-administered antidotes in modern emergency medicine.

What's new is the longevity translation. Glutathione is the body's most abundant intracellular antioxidant — present in every cell at 1–10 millimolar concentrations (more than 1000-fold higher than plasma vitamin C), doing the unglamorous daily work of neutralizing reactive oxygen species, recycling oxidized vitamins C and E, conjugating heavy metals and xenobiotics for biliary or renal excretion, and keeping the redox-sensitive transcription factors (Nrf2, NF-κB, FOXO, AP-1) tuned. The catch: glutathione synthesis collapses with age. Cross-sectional human work (Sekhar 2018, Clin Transl Med; Sekhar 2011, Am J Clin Nutr) shows older adults run intracellular glutathione 30–60% below young controls, with parallel rises in oxidative-damage markers (F2-isoprostanes, malondialdehyde, 8-OHdG), mitochondrial dysfunction, and inflammatory tone. Replacing the missing precursor — cysteine, via NAC — restores glutathione synthesis, and the downstream antioxidant, anti-inflammatory, and mitochondrial markers move with it.

NAC and the Hallmarks of Aging

The 2013 López-Otín paper in Cell — updated in 2023 to twelve hallmarks — is the field's reference taxonomy for what actually goes wrong as humans age. NAC, working through glutathione, touches an unusually large fraction of them:

• Mitochondrial dysfunction. Glutathione is the dominant antioxidant inside the mitochondrion. As mitochondrial GSH (mGSH) declines, the inner-membrane lipids oxidize, the electron transport chain leaks more electrons as superoxide, and the cycle accelerates. The 2021 Sekhar trial showed measurable improvements in mitochondrial fuel oxidation after 24 weeks of GlyNAC.
• Loss of proteostasis. Glutathione participates in protein-folding fidelity (forming and reducing disulfide bonds in the endoplasmic reticulum) and is required for the function of glutathione-S-transferases that conjugate and clear damaged proteins. Glutathione depletion drives endoplasmic-reticulum stress and the unfolded-protein response.
• Genomic instability. 8-OHdG, the canonical oxidative DNA damage marker, rises when glutathione falls. Restoring glutathione lowers genotoxicity (measured directly in the 2021 Sekhar trial via the comet assay).
• Altered intercellular communication / chronic inflammation. Glutathione tunes NF-κB activity. As GSH falls, NF-κB activates inappropriately, IL-6 and TNF-α rise, and the “inflammaging” phenotype emerges. Sekhar 2021 showed both markers fell with GlyNAC.
• Deregulated nutrient sensing. Insulin sensitivity improved measurably in both the 2013 (diabetic elderly, Diabetes Care) and 2021 (older adults, Clin Transl Med) trials.
• Stem cell exhaustion. Hematopoietic and tissue stem cells live in low-oxygen niches with high glutathione. GSH depletion is one of the early triggers of stem-cell senescence in vitro.

This is the “lever” logic: a single intervention (restore the cysteine–glutathione axis) acts upstream of multiple hallmarks at once, which is why GlyNAC is the only nutrient combination to date that has produced the breadth of measured improvements that Kumar 2021 reported across cellular, metabolic, and functional domains.

The Sekhar GlyNAC trials — what NAC actually did in older humans

The reason NAC moved from “pharmacy back-shelf” to “longevity headline” is the GlyNAC research program from Rajagopal Sekhar's lab at Baylor College of Medicine. The hypothesis: if older adults are glutathione-deficient because they run short on the precursors cysteine and glycine, then giving them both — Glycine + N-Acetyl-Cysteine — should restore glutathione and reverse the downstream aging biology.

The trials, in sequence:

1. 2011 (Diabetes Care) — Sekhar's first proof-of-concept. 12 elderly adults with diabetes, 14 days of cysteine + glycine. Glutathione synthesis rose +230%, intracellular glutathione doubled, oxidative stress markers fell, and insulin resistance improved. First proof the precursor-restoration model worked in humans.
2. 2011 (Am J Clin Nutr) — same precursor-restoration approach in 8 older adults vs. 8 young controls. Confirmed older adults at baseline ran ~50% lower glutathione, ~80% higher oxidative stress, and impaired mitochondrial fuel oxidation. Two weeks of cysteine + glycine normalized glutathione and oxidative stress to young-control levels.
3. 2014 (J Clin Endocrinol Metab) — Nguyen, Hsu, Jahoor, Sekhar. Same protocol in older HIV-aging patients (premature-aging phenotype amplified). Mitochondrial fuel oxidation, insulin sensitivity, and body composition all improved.
4. 2018 (Clin Transl Med) — replication in older adults vs. young controls, deeper mitochondrial analysis (palmitate & glucose oxidation rates), with the addition of mtDNA copy-number metrics. Same pattern: precursor restoration, glutathione rebuild, mitochondrial recovery toward young controls.
5. 2021 (Clin Transl Med) — the headline trial. 24-week randomized, placebo-controlled study in older adults (ages 71–80). GlyNAC supplementation (1.33 mmol/kg/day glycine + 0.81 mmol/kg/day NAC, weight-adjusted) measurably improved glutathione, oxidative stress, mitochondrial function, inflammation, insulin resistance, endothelial function, genotoxicity, body composition, gait speed, strength, exercise capacity, waist circumference, and cognition. The authors framed it as reversal of the major hallmarks of aging — the most ambitious claim in any nutrient trial to date.
6. 2022 (J Gerontol A Biol Sci Med Sci) — Kumar, Liu, Hsu, Sekhar. Replication and extension in HIV-aging populations, where premature aging biology is amplified. Same pattern: glutathione restored, mitochondrial function improved, oxidative stress fell, body composition shifted toward more lean mass.
7. 2023 (Antioxidants) — Kumar, Sekhar follow-up commentary mapping each measured outcome to a specific López-Otín hallmark, formalizing the “GlyNAC reverses multiple hallmarks” framing now widely cited.

The doses used in the 2021 trial — when scaled to a typical 70 kg adult — work out to roughly 3.6g NAC + 4.5g glycine per day, split twice daily with meals. Our NAC 600mg pairs naturally with our Glycine 1500mg | GlyNAC Partner capsule — one of each, twice daily, gives you ~1200mg NAC and ~3000mg glycine, a foundational maintenance dose. Adults running the full Sekhar-style protocol typically take 2 of each capsule twice daily; this is well within the safe range that the trials used (the FDA-approved IV NAC overdose protocol is ~14g over 21 hours, so oral 2.4g/day is conservative by an order of magnitude).

One caveat the 2021 paper makes explicit: both precursors matter. The 30–60% intracellular glutathione deficit in older adults is driven by both cysteine and glycine running short, not cysteine alone. NAC by itself raises glutathione, but the GlyNAC combination raises it further and produces the measured functional improvements. If you are running the longevity protocol seriously, run the pair.

Three things NAC does (the mechanism, in plain English)

1. Glutathione regeneration (the main event)

NAC is hydrolyzed to L-cysteine in the gut and liver, and cysteine is the rate-limiting amino acid in glutathione synthesis. The other two glutathione amino acids — glycine and glutamate — are abundant in the diet and rarely limit synthesis except in the very elderly. Cysteine is the choke point because dietary cysteine is largely consumed building proteins, and the free cysteine pool is kept deliberately small (free cysteine is reactive and cytotoxic). NAC's acetyl group protects the thiol from oxidation in transit, lets the molecule survive the gut, and is cleaved by tissue deacetylases to release usable cysteine intracellularly. The two-step glutathione synthesis pathway (γ-glutamylcysteine synthetase / GCL is rate-limiting at step one; glutathione synthetase finishes step two) is then substrate-driven — provide cysteine, glutathione synthesis goes up.

Once made, glutathione cycles between its reduced (GSH) and oxidized (GSSG) forms. The GSH:GSSG ratio is the single most-cited cellular redox indicator — healthy cells run ~100:1 GSH:GSSG, oxidatively-stressed cells drop toward 10:1 or lower. NAC restoration moves the ratio back toward the youthful state, and that ratio is what the rest of the cell's redox-sensitive machinery (Nrf2, NF-κB, AP-1, MAPK pathways) reads to decide its behavior.

2. Direct disulfide-breaking action

NAC's thiol (-SH) directly reduces disulfide bonds (-S-S-) in proteins and mucus glycoproteins. This is the mechanism behind NAC's mucolytic activity (used in cystic fibrosis, chronic bronchitis, COPD — PANTHEON 2014, BRONCUS 2005), and it also matters for redox-active extracellular proteins in inflammation. The thiol-disulfide exchange is fast, non-enzymatic, and works in the gut, the airway lining, and the bloodstream.

3. Direct ROS scavenging, metal chelation, and Nrf2/KEAP1 signaling

Aside from glutathione regeneration, NAC's free thiol can directly neutralize hydroxyl radicals, hypochlorous acid, and nitrogen dioxide. It chelates heavy metals (copper, mercury, lead, cadmium) and supports their biliary clearance via glutathione conjugation. And it tunes the Nrf2/KEAP1 cascade — the master “turn on the antioxidant gene set” switch.

The KEAP1 mechanism is worth knowing in detail because it explains why a small daily NAC dose can produce sustained downstream protection: KEAP1 is a cytoplasmic protein that holds Nrf2 in the cytoplasm and tags it for degradation under normal conditions. Oxidative or electrophilic modification of specific KEAP1 cysteine residues (especially Cys151, Cys273, Cys288) releases Nrf2, which then translocates to the nucleus and drives transcription of ~250 cytoprotective genes — including the glutathione-synthesis enzymes themselves (GCLC, GCLM, GS), thioredoxin, NQO1, heme oxygenase-1, and the glutathione-S-transferases. NAC and glutathione participate in this loop: GSH availability tunes the resting redox state that KEAP1's cysteines see, and the resulting Nrf2 tone determines how much glutathione-synthesis enzyme is around to make use of new cysteine arriving from a NAC capsule. Boost cysteine availability and the upstream substrate, downstream enzyme expression, and the resulting GSH:GSSG ratio all move together — this feed-forward is why you see broad protective effects from a relatively simple intervention.

The glutathione cycle — production, use, and recycling

It helps to know what happens to a cysteine molecule once it crosses the cell membrane. The full cycle:

• Step 1 (rate-limiting): GCL combines cysteine + glutamate → γ-glutamylcysteine. GCL (glutamate-cysteine ligase) is feedback-inhibited by GSH itself, so when glutathione is high the enzyme slows; when glutathione is low and cysteine is available, the enzyme is unleashed.
• Step 2: GS combines γ-glutamylcysteine + glycine → GSH. Glycine availability matters here, which is why the GlyNAC pairing exists.
• Step 3: GSH neutralizes ROS via glutathione peroxidase (GPx), with selenium as the catalytic cofactor (1 selenocysteine per GPx active site). Two GSH molecules + H₂O₂ → GSSG + 2 H₂O. This is one reason the 2009 Safarinejad fertility trial paired NAC with selenium — selenium is the catalytic site of the enzyme that uses glutathione.
• Step 4: GSSG is recycled to GSH via glutathione reductase (GR), using NADPH from the pentose phosphate pathway. NADPH is the actual redox “currency” that drives the recycling, which is why metabolic conditions that limit NADPH (G6PD deficiency, certain medications) also limit glutathione recycling.
• Step 5: Conjugation and excretion. Glutathione-S-transferases (GSTs) tag xenobiotics, heavy metals, and Phase-1-activated drug intermediates with GSH for biliary or urinary excretion. This is the “detox” arm — not magical detoxification, just the actual molecular pathway by which the liver clears reactive species.

Cysteine availability is the rate-determining input to step 1. Glycine availability matters at step 2. Selenium matters at step 3. NADPH matters at step 4. The full nutritional support stack for the glutathione cycle is therefore: NAC + glycine + selenium-containing food (Brazil nuts, fish) + good metabolic status (B-vitamins, magnesium for the PPP). Pair NAC with our Glycine 1500mg and a selenium-rich diet and you have all four covered.

Beyond glutathione — the secondary clinical literature

Acetaminophen-overdose antidote (the founding evidence)

Acetaminophen overdose kills via NAPQI — a reactive Phase-1 metabolite that conjugates with hepatic glutathione. Under therapeutic dosing, glutathione handles the small amount of NAPQI generated. Under overdose, glutathione is consumed, NAPQI binds covalently to liver proteins, and centrilobular necrosis follows. NAC, given within 8–10 hours, restores glutathione faster than NAPQI can deplete it (Smilkstein 1988, NEJM; Prescott 1979, Lancet). The IV protocol — 150 mg/kg loading, 50 mg/kg over 4 hours, 100 mg/kg over 16 hours — remains the most-cited validation that cysteine availability determines glutathione synthesis rate in living human livers.

Fertility and reproductive health

Both male and female fertility are downstream of redox balance, and NAC has trial-grade evidence on both sides. Female fertility / PCOS: a 2015 systematic review and meta-analysis (Thakker, Obstet Gynecol Int) of 8 RCTs found NAC improved ovulation rate, pregnancy rate, and metabolic indices in women with PCOS, including in clomiphene-resistant cases, with effect sizes comparable to metformin in head-to-head comparisons. Male fertility: the 2009 Safarinejad RCT in J Urol (468 infertile men, 26 weeks of NAC + selenium) showed measurable improvements in sperm concentration, motility, and morphology, with reductions in seminal-plasma malondialdehyde (oxidative damage to sperm membranes is a leading cause of unexplained male-factor infertility). The mechanism in both cases is glutathione-dependent: oocyte and sperm membranes are unusually rich in polyunsaturated lipids, ovarian and testicular tissue runs at high metabolic rate, and oxidative damage accumulates fastest where lipid + heat + metabolism collide. Pair our NAC with CoQ10 400mg for the established “antioxidant + mitochondrial bioenergetics” fertility stack — this combination is widely used in IVF prep clinics.

Respiratory health

NAC's mucolytic effect is the original FDA indication. Two large COPD trials anchor the modern dosing: BRONCUS (Decramer 2005, Lancet) — 600mg/day for 3 years did not reduce FEV1 decline overall but reduced exacerbations in patients not on inhaled corticosteroids. PANTHEON (Zheng 2014, Lancet Respir Med) — 600mg twice daily for 1 year reduced exacerbation frequency by 22% in moderate-severe COPD (incidence rate ratio 0.78, 95% CI 0.67–0.90). Higher doses (1200mg twice daily) have been used in idiopathic pulmonary fibrosis trials with mixed results (PANTHER-IPF).

Mental health and the glutamate/dopamine system

NAC modulates the cystine-glutamate antiporter (xCT/system x_c^-) on glial cells, reducing presynaptic glutamate release and tuning glutamatergic tone. It is the most-studied glutamate-modulating supplement in psychiatry. Trial-grade evidence:

• Bipolar depression (Berk 2008, Biol Psychiatry) — 1g twice daily for 24 weeks improved depressive symptoms and global function vs. placebo.
• Trichotillomania (Grant 2009, Arch Gen Psychiatry) — 1.2–2.4g/day for 12 weeks: 56% of NAC subjects improved vs. 16% on placebo.
• OCD (multiple RCTs since 2012) — adjunct to SSRI; mixed but generally favorable.
• Schizophrenia (Berk 2008b) — 2g/day adjunct, modest improvements in negative symptoms.

NAC is not a primary psychiatric treatment. It is a glutamate-modulating adjunct with a benign side-effect profile, used in research and specialist practice for OCD-spectrum disorders, treatment-resistant mood disorders, and as a safer alternative to escalating other agents.

Liver and detoxification

Beyond the acute-overdose use, NAC has been studied in non-alcoholic fatty liver disease (Khoshbaten 2010, Hepat Mon: improved ALT/AST, hepatic enzymes, and steatosis on ultrasound), in alcoholic liver disease as glutathione support, and in chemoprotection during chemotherapy (controversial — see “What NOT to do” below). The detoxification pathway is glutathione-S-transferase-driven conjugation, the same route that handles most drug, environmental, and endogenous toxins. Heavy-metal chelation via glutathione is a documented secondary benefit (Atkuri 2007, Curr Opin Pharmacol).

Contrast-induced nephropathy

Tepel 2000 (NEJM) was the first major RCT to show NAC + saline reduced acute kidney injury after contrast imaging in chronic kidney disease patients. The literature has mixed since (the 2018 PRESERVE trial in NEJM was negative), but NAC remains in many institutional CIN-prevention protocols because it is cheap, safe, and the upside is preventable AKI in vulnerable patients. The mechanism is glutathione-supported renal-tubule protection plus direct ROS scavenging.

Inflammation and post-viral syndromes

The 2020–2022 literature included multiple small trials of NAC in COVID-19 and post-viral inflammation, with mixed but generally favorable findings on inflammatory markers (CRP, ferritin, IL-6) and clinical course. The biological logic is the same as in any inflammatory state: glutathione depletion is downstream of severe inflammation, and restoring it with the precursor reduces cytokine amplification. NAC is not a treatment for any specific viral illness, but glutathione restoration is reasonable supportive nutrition during prolonged inflammatory states.

What's in the bottle

Each capsule delivers 600mg pharmaceutical-grade N-Acetyl-L-Cysteine — the dose used in PANTHEON, the GlyNAC pilot work, and most of the major clinical trials. 60 capsules per bottle gives a 30-day supply at the foundational longevity dose (1 cap AM + 1 cap PM = 1200mg/day, the dose that stacks naturally with our Glycine 1500mg).

• Active: 600mg N-Acetyl-L-Cysteine (USP/EP-grade, identity-tested by HPLC-UV at 214 nm against a USP reference standard, assay 99.0–100.5%).
• Capsule: vegetarian (HPMC), no animal-derived gelatin.
• Excipients: microcrystalline cellulose (flow agent), no magnesium stearate, no titanium dioxide, no silicon dioxide as primary filler (used only at trace levels for capsule-filling consistency).
• Free of: gluten, soy, dairy, eggs, peanuts, tree nuts (manufactured on shared lines — allergen-trace tested), shellfish, fish, sesame, GMO ingredients.
• Manufacturing: GMP-certified U.S. facility, NSF-audited, GFSI-aligned allergen control program. Each batch carries a Certificate of Analysis (CoA) covering identity (HPLC-UV), assay, dissolution (USP <711>), heavy metals (ICP-MS for As/Cd/Pb/Hg vs. USP <232>/<233>), and microbiology (total aerobic count, yeast/mold, E. coli, Salmonella, S. aureus) per batch. CoAs are available on request — we publish lot numbers and dates with every shipment.
• Stability: NAC's free thiol is mildly oxidation-prone, so capsules are blister-packed where possible and bottle-stocked otherwise with desiccant. Best stored cool, dry, and capped tight after opening. Sulfur smell on opening is the thiol — expected and harmless. If the smell intensifies dramatically over time, the product has oxidized and should be replaced.

How to take it

Foundational longevity dose — 600–1200mg/day

1 capsule with breakfast and 1 capsule with dinner. With food reduces the modest GI tolerance issues some users notice (NAC is mildly stomach-irritating in a small fraction of people on an empty stomach). 1200mg/day is the dose used as the “maintenance” arm in long-term respiratory and cardiovascular trials and is the dose we recommend for most adults running NAC as a foundational antioxidant.

GlyNAC protocol — pair with Glycine 1500mg, twice daily

For the Sekhar protocol — the one with the 2021 trial data — pair 1 NAC capsule with 1–2 Glycine 1500mg capsules at breakfast, repeat at dinner. Adults running the full clinical-trial dose (~3.6g NAC + 4.5g glycine/day, weight-adjusted) take 2 of each capsule twice daily. This is the protocol with the breadth-of-hallmarks effect data; it is not necessary for most users but it is the most ambitious, evidence-backed antioxidant intervention in the modern nutrition literature.

PCOS / fertility protocol — 1200–1800mg/day

Trial doses for PCOS run 600mg twice or three times daily. Pair with CoQ10 400mg for the standard fertility-clinic antioxidant pair, taken with breakfast (CoQ10 absorbs best with dietary fat). Cycle alongside any clinician-directed reproductive treatment; communicate with your fertility specialist about all supplementation.

Respiratory / mucolytic — 600–1800mg/day

1 cap morning, 1 cap evening for chronic respiratory support; up to 3/day during acute illness for short courses. The original effervescent-tablet formulation in Europe runs 600mg dissolved in water; capsules deliver the same dose with the same bioavailability after dissolution.

Athletic / pre-exercise considerations

One important caveat: NAC taken pre-exercise blunts some training adaptations. Petersen 2012 (Acta Physiol) showed acute NAC infusion attenuated the early adaptive response in human skeletal muscle. The mechanism is the “Ristow window”: exercise-generated ROS are not just damage signals — they are the training stimulus. Mitochondrial biogenesis, capillary density, and antioxidant-enzyme upregulation are downstream of transient post-exercise ROS spikes. Quench the spike with high-dose NAC (or vitamin C, see Ristow 2009 PNAS) and you blunt the adaptation.

Practical rule: if you train hard and care about adaptation, do not take NAC in the 2–3 hours before or 1–2 hours after training. Take it with breakfast and dinner if morning-training, or with breakfast and afternoon if evening-training. The 24-hour exposure is what matters for glutathione restoration; the temporary post-exercise window matters for adaptation.

What NOT to do

• Do not take NAC with nitroglycerin. NAC potentiates nitroglycerin's vasodilator effect dramatically and can cause severe headache and hypotension.
• Do not take NAC immediately before/after exercise if you are training for adaptation — see Ristow 2009 and Petersen 2012 above.
• Do not stack high-dose NAC during active chemotherapy without oncologist approval. Some chemotherapy agents work via oxidative mechanisms; antioxidant support during active treatment is a discussion to have with your oncology team.
• Do not exceed 3g/day chronically without clinical indication. The trial doses are 1.2–2.4g/day for most uses; the 3.6g/day GlyNAC dose is weight-adjusted and trial-supervised.
• Do not take NAC if you have a documented sulfur-thiol allergy (rare but real).

Daily schedule (foundational placement)

• Breakfast: 1 NAC capsule + 1–2 Glycine + your NMN/Resveratrol stack + a methyl donor (TMG) if running NMN.
• Lunch: optional second NAC capsule with food if running 1800mg/day.
• Dinner: 1 NAC capsule + 1–2 Glycine + Magnesium Glycinate for sleep.
• Pre-bed: nothing extra. NAC has no stimulant or sedative effect of its own; the glycine in the GlyNAC pair has a mild slow-wave-sleep benefit but is not sedating.

Some users prefer all NAC dosing in the AM if evening intake produces vivid dreams (uncommon but reported — the cysteine-glutamate axis can subtly alter dream architecture in sensitive individuals). Move both doses to AM/lunch if this affects you.

Stack pairings — what each pair actually does

• NAC + Glycine 1500mg — the literal GlyNAC pair from Sekhar's lab. The pair the 2021 trial used. The single most evidence-backed antioxidant nutrient combination in modern aging biology.
• NAC + Glutathione 500mg — precursor + finished product, the “belt and suspenders” combination. Some users prefer the direct GSH for extracellular redox support and use NAC for intracellular synthesis. The two are not redundant; oral GSH is partially deglutathionylated in transit, and the cell still has to remake it from precursors. Most people benefit more from NAC alone; the combination is for users with elevated baseline oxidative stress.
• NAC + Alpha-Lipoic Acid 600mg — the “universal antioxidant” pair. ALA is amphipathic (works in lipid and water phases) and recycles glutathione, vitamin C, and vitamin E. The combination is used in diabetic-neuropathy and fertility protocols.
• NAC + CoQ10 400mg — antioxidant + mitochondrial bioenergetics. Standard fertility-clinic prep stack and good general mitochondrial support, especially over 40 when endogenous CoQ10 falls.
• NAC + NMN / Resveratrol — the “run the engine harder, change the oil more often” logic. NAD+ precursors accelerate mitochondrial activity; NAC provides the antioxidant defense that protects the cellular machinery from the additional metabolic flux. Some experienced longevity stackers consider NAC essentially mandatory if running NMN long-term.
• NAC + selenium-rich diet (Brazil nuts, fish, eggs) — selenium is the catalytic core of glutathione peroxidase. Without selenium, glutathione cannot do its peroxide-neutralizing job. We do not currently sell a standalone selenium product because dietary intake is generally adequate; if your diet is low in selenium-rich foods, an inexpensive standalone selenium yeast supplement closes the gap.

Who this is for

• Adults 40+ running a serious longevity or healthspan protocol — the population in which intracellular glutathione has measurably declined and the precursor-restoration logic is most validated.
• Anyone running NMN, NR, or NAD+ precursors — antioxidant defense scales with mitochondrial activity.
• People with respiratory conditions or chronic mucus burden (COPD, chronic bronchitis, post-viral persistent cough) — the original mucolytic indication.
• Adults working on fertility — PCOS, unexplained infertility, IVF prep, male oxidative-stress sperm parameters.
• People with elevated oxidative-stress markers (high F2-isoprostanes, low GSH:GSSG ratio, elevated 8-OHdG) on functional bloodwork.
• People wanting liver-support nutrition during periods of higher xenobiotic exposure (alcohol use, environmental load, certain medication courses).
• Adults running mental-health protocols where glutamate modulation is therapeutically relevant (under clinician supervision).

Who this isn't for

• Children — pediatric NAC dosing is medical, not OTC.
• Pregnant or nursing women without obstetrician approval — safety data exist but supervised use is the right model.
• Patients on nitroglycerin (severe potentiation risk).
• Patients in active chemotherapy without oncologist approval.
• People with documented sulfur-thiol or NAC-specific allergy.
• Athletes during pure-adaptation training blocks who want to maximize the Ristow window — time NAC away from training as described above, or pause during a focused adaptation block.

Frequently asked questions

Is NAC the same as glutathione?

No. Glutathione is the finished tripeptide (cysteine-glutamate-glycine) the cell makes; NAC is the cysteine precursor. Oral glutathione is partially deglutathionylated in the gut and absorbed as its component amino acids, then reassembled inside cells. Oral NAC reliably raises intracellular glutathione because it provides the rate-limiting precursor; oral glutathione is more variable. Both are useful; NAC is the more cost-effective, evidence-backed, intracellular-target option.

What about GlyNAC — do I need glycine too?

If you are running NAC for general antioxidant support, NAC alone works fine. If you are running the Sekhar protocol — the one with the 2021 hallmarks-of-aging effect data — yes, glycine matters. The 30–60% intracellular GSH deficit in older adults is driven by both cysteine and glycine running short. The GlyNAC pair is what produced the breadth of measured improvements (gait speed, strength, cognition, body composition, insulin sensitivity, etc.) in the 24-week trial. Our Glycine 1500mg is dosed and labeled to pair 1:1 with NAC.

How much will my glutathione actually rise?

The GlyNAC trials measured ~100% rises in intracellular glutathione (back to young-adult levels) within 14 days. NAC alone produces a smaller rise — published estimates run 30–80% — but still substantial, especially in older adults starting from low baselines. The rise is dose-dependent; 1200mg/day gives a meaningful effect, 2400mg/day gives more, with diminishing returns above ~3g/day.

Why 600mg per capsule and not 1200mg?

600mg is the canonical NAC dose used in PANTHEON, BRONCUS, the contrast-nephropathy trials, and the bipolar/OCD literature — making it the most-validated single-capsule serving in the clinical record. It also gives users dose flexibility (600mg, 1200mg, 1800mg, 2400mg/day all reachable in 1-cap multiples). 1200mg single capsules are physically too large to swallow for most people; the 600mg HPMC capsule is the standard form factor across the supplement industry.

Will it make my breath / sweat smell like sulfur?

Some people notice a faint sulfur smell on opening the bottle (this is the thiol; expected and harmless). A small fraction of users notice mild sulfurous breath, especially at higher doses (1800mg+). It is reversible — reduce dose and take with food. The bottle smell does not transfer meaningfully to the user.

Does NAC help with hangovers?

Mechanistically yes — ethanol metabolism (acetaldehyde → acetate via ALDH2) consumes glutathione, and NAC provides the precursor to rebuild it. Empirically the hangover-prevention literature is mostly anecdotal and small-n. Common practice: 600mg NAC pre-drinking + 600mg the next morning. Not a license to drink more — alcohol still causes the rest of its damage independent of glutathione status.

Does NAC interfere with the benefit of exercise?

If taken in the immediate window around training (2 hours before to 1–2 hours after), high-dose NAC and high-dose vitamin C blunt some training adaptations because they quench the post-exercise ROS spike that is itself the adaptation signal (Ristow 2009 PNAS; Petersen 2012 Acta Physiol). Take NAC 4+ hours away from training and this is not an issue. Daily glutathione restoration is still useful for anyone training hard — the training protects mitochondria longer-term, glutathione protects them in the meantime.

Can I take NAC with NMN or NAD+ products?

Yes, and we recommend the combination. NMN and NR raise NAD+, which accelerates sirtuin and mitochondrial activity, which generates more reactive oxygen species as a byproduct. NAC restores glutathione, which neutralizes the byproducts. The two stack synergistically; many serious longevity stacks treat the NMN+NAC combination as the foundational pairing along with a methyl donor like TMG.

What's the difference between NAC and L-cysteine?

L-cysteine is the bare amino acid — chemically reactive, prone to oxidation, and cytotoxic at high free concentrations (which is why the body keeps the free pool small). NAC has an acetyl group on the amino nitrogen that protects the thiol from oxidation in transit, allows the molecule to survive gut and first-pass conditions, and is cleaved by tissue deacetylases to release usable cysteine intracellularly. NAC is the supplement-form-factor of cysteine that is actually safe and bioavailable to take in gram quantities daily.

Why don't I see selenium in this capsule?

We chose to keep NAC clean (single-active capsule) so users can stack flexibly. Selenium matters for glutathione peroxidase activity (it sits at the catalytic core), but most adults get adequate selenium from diet (Brazil nuts are an exceptional source — one nut covers daily needs). If your diet is low in selenium-rich foods, an inexpensive selenium-yeast standalone supplement closes the gap and stacks fine with NAC. Combined NAC+selenium products exist; we will likely offer one in a future SKU.

How long until I notice anything?

Subjectively, most users notice nothing acutely — NAC's effect is on cellular biochemistry rather than immediate sensation. Users running it for fertility, respiratory, or mood indications typically report effects at 4–12 weeks. Glutathione synthesis itself responds within days (the Sekhar 14-day pilots showed full restoration); functional outcomes follow as the restored redox balance plays out across tissues. If you have functional bloodwork, repeat F2-isoprostanes, GSH:GSSG, or 8-OHdG at 12 weeks to see the effect.

Do I need to cycle off NAC?

No. NAC has been used continuously in trials for 3+ years (BRONCUS) without dose-related tolerance or rebound effects. Some users prefer to run weekend washouts to confirm continued sensitivity to other parts of their stack — that's a personal preference, not a biochemical requirement. There is no evidence that chronic NAC induces tolerance or homeostatic glutathione downregulation; the cysteine remains the rate-limiting input regardless of how long supplementation has run.

Can I open the capsule and mix the powder?

Yes, though NAC is bitter and sulfurous. Mix into smoothies, fruit juice, or any strong-flavored beverage. Do not mix into hot tea or coffee (heat accelerates thiol oxidation). For users who want a powder format directly, we plan to release a flavored NAC powder in the future.

Does NAC raise homocysteine?

This is a sometimes-circulated concern based on the methionine–cysteine biochemistry. In published trials, NAC does not raise serum homocysteine in healthy adults (Wiklund 1996, Am J Clin Nutr; multiple others). NAC enters the cysteine pool downstream of the trans-sulfuration pathway, so it does not need to be made from methionine and does not push homocysteine flux. Adequate B12, folate, and B6 (or supplementation if low) maintains the methylation cycle that handles any homocysteine generated; pair with TMG if you are running NMN.

Can I take NAC during pregnancy?

NAC has been used in pregnancy in clinical settings (it is the antidote of choice for acetaminophen overdose during pregnancy, and has been studied for pregnancy-related complications of oxidative stress). However, supplementation during pregnancy or nursing should be supervised by your obstetrician. We do not recommend self-prescribed NAC during pregnancy.

Will NAC interfere with my medications?

The major drug interaction is nitroglycerin (severe vasodilator potentiation). Modest interactions to be aware of: anticoagulants (potential mild antiplatelet effect), immunosuppressants (theoretical, not strongly documented), and active-treatment chemotherapy (oxidant-mechanism agents). Always disclose all supplements to your prescribing clinician.

What's your third-party testing setup?

Identity by HPLC-UV against USP reference standard at 214 nm; assay 99.0–100.5%; dissolution per USP <711>; heavy metals (As, Cd, Pb, Hg) by ICP-MS against USP <232>/<233> elemental-impurity limits; microbiology (TAMC, TYMC, E. coli, Salmonella, S. aureus) per USP <61>/<62>. Each batch carries a Certificate of Analysis we can share on request — lot number and best-by date are on every bottle. Manufacturer is a U.S.-based GMP-certified, NSF-audited contract facility.

How does NAC compare to liposomal glutathione?

Liposomal glutathione raises plasma GSH directly but at substantial cost, with variable absorption depending on liposome quality. NAC raises intracellular GSH via the cell's own synthesis pathway, with decades of trial data behind specific dose-effect relationships. For most users, NAC is the more cost-effective and better-validated choice. The two can be combined for users with severe oxidative-stress phenotypes; routine use does not require both.

Quality & sourcing

NAC is one of the simplest molecules in the cabinet to source poorly — cheap commodity-grade NAC carries assay variability, residual solvents, and (occasionally) heavy-metal contamination that the consumer never sees. We use pharmaceutical-grade USP/EP-spec NAC, identity-tested by HPLC-UV against a USP reference standard, with full-panel heavy metals and microbiology per batch. Capsules are vegetarian HPMC, free of titanium dioxide, magnesium stearate, or unnecessary excipients. Manufactured in a U.S. GMP-certified, NSF-audited facility with a GFSI-aligned allergen-control program. Each batch carries a Certificate of Analysis that we will provide on request — CoAs include identity, assay, dissolution, heavy metals, and microbiology results. We publish lot numbers and best-by dates on every bottle. Storage: cool, dry, capped tight; the mild sulfur smell on opening is the thiol — expected. If the smell intensifies dramatically over storage, the product has oxidized and we will replace it under our 30-day guarantee.

For deeper context on our manufacturing standards, see Quality and Ingredient Sourcing.

Where this sits in the True Health Protocol catalog

NAC sits at the heart of the antioxidant arm of the catalog, alongside our Glycine 1500mg (the GlyNAC partner), Glutathione 500mg (the finished tripeptide for direct extracellular redox support), Alpha-Lipoic Acid 600mg (the universal-antioxidant amphipathic recycler), and the broader Antioxidants collection. As the rate-limiting precursor to glutathione, it is one of three or four ingredients we consider truly foundational for any healthspan protocol — alongside NMN for the NAD+ axis, CoQ10 for mitochondrial bioenergetics, and Magnesium Glycinate for sleep and methylation cofactor support. See Foundational Health for the curated short-list, Mitochondrial Renewal for the mitochondrial subset, Fertility for the reproductive use-case, NAD+ Family for the NAD+ stack, and Protocols for full daily templates.

If you are new to the catalog, Getting Started walks through how to build a stack from foundational pieces; Our Science covers the Hallmarks-of-Aging frame; How It Works explains the mechanism logic across the catalog; and FAQ covers the most common cross-product questions.

Shipping and returns: see Shipping Policy and 30-Day Refund Policy. Terms: Terms of Service.

Disclaimer

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Discuss with your physician before starting if you are pregnant or nursing, taking medication (especially nitroglycerin, anticoagulants, or immunosuppressants), or have a chronic medical condition. Discontinue and consult a clinician if you experience unusual GI distress, rash, or shortness of breath.

Selected references

• Kumar P, Liu C, Hsu JW, et al. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: results of a pilot clinical trial. Clin Transl Med. 2021;11(3):e372.
• Kumar P, Osahon OW, Sekhar RV. GlyNAC (glycine and N-acetylcysteine) supplementation in old mice improves brain glutathione deficiency, oxidative stress, glucose uptake, mitochondrial dysfunction, genomic damage, inflammation and neurotrophic factors. Antioxidants. 2023;12(5):1042.
• Kumar P, Liu C, Hsu JW, et al. GlyNAC supplementation in older HIV-infected adults: improvements in glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, strength, and cognition. J Gerontol A Biol Sci Med Sci. 2022;77(1):75-89.
• Sekhar RV, Patel SG, Guthikonda AP, et al. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr. 2011;94(3):847-853.
• Sekhar RV, McKay SV, Patel SG, et al. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care. 2011;34(1):162-167.
• Sekhar RV. GlyNAC (glycine and N-acetylcysteine) supplementation improves impaired mitochondrial fuel oxidation and lowers insulin resistance in patients with type 2 diabetes: results of a pilot study. Antioxidants. 2021;10(7):1054.
• Nguyen D, Hsu JW, Jahoor F, Sekhar RV. Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older HIV-infected patients. J Clin Endocrinol Metab. 2014;99(1):169-177.
• Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-Acetylcysteine — a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007;7(4):355-359.
• Šalamon Š, Kramar B, Marolt TP, et al. Medical and dietary uses of N-acetylcysteine. Antioxidants. 2019;8(5):111.
• Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988;319(24):1557-1562.
• Prescott LF, Park J, Ballantyne A, Adriaenssens P, Proudfoot AT. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet. 1977;2(8035):432-434.
• Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343(3):180-184.
• Decramer M, Rutten-van Mölken M, Dekhuijzen PN, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet. 2005;365(9470):1552-1560.
• Zheng JP, Wen FQ, Bai CX, et al. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. Lancet Respir Med. 2014;2(3):187-194.
• Berk M, Copolov DL, Dean O, et al. N-acetyl cysteine for depressive symptoms in bipolar disorder — a double-blind randomized placebo-controlled trial. Biol Psychiatry. 2008;64(6):468-475.
• Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2009;66(7):756-763.
• Thakker D, Raval A, Patel I, Walia R. N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Obstet Gynecol Int. 2015;2015:817849.
• Safarinejad MR, Safarinejad S. Efficacy of selenium and/or N-acetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. J Urol. 2009;181(2):741-751.
• Khoshbaten M, Aliasgarzadeh A, Masnadi K, et al. N-acetylcysteine improves liver function in patients with non-alcoholic fatty liver disease. Hepat Mon. 2010;10(1):12-16.
• Petersen AC, McKenna MJ, Medved I, et al. Infusion with the antioxidant N-acetylcysteine attenuates early adaptive responses to exercise in human skeletal muscle. Acta Physiol. 2012;204(3):382-392.
• Ristow M, Zarse K, Oberbach A, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA. 2009;106(21):8665-8670.
• López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194-1217.
• López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243-278.
• Wiklund O, Fager G, Andersson A, Lundstam U, Masson P, Hultberg B. N-acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels. Atherosclerosis. 1996;119(1):99-106.
• Dekhuijzen PNR. Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur Respir J. 2004;23(4):629-636.
• Sadowska AM, Manuel-y-Keenoy B, De Backer WA. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm Pharmacol Ther. 2007;20(1):9-22.